Friday, February 23, 2024
wellness India Expo
Home Tags ICGEB

Tag: ICGEB

Global Biofuel Alliance – An opportunity for indigenous technologies to fulfil...

India has surplus biomass residues in the range of ~200 million tonnes that can be converted into biofuels, writes Dr Syed Shams Yazdani

BioVoice eMagazine October 2023 | Issue 10 | Volume 4

The Cover Story analyzes the launch of Global Biofuel Alliance at G20 Summit with Expert Insights by Dr Syed Shams Yazdani, Group Leader, ICGEB-New Delhi. Read a series of power-packed interviews featuring Raghav Priyadarshi, CEO, Savikalpa Sciences; Amit Gandhi, CBO, DeepTek.ai; and Anuj Kumbhat, CEO, WRMS. Startup Special story features Mumbai based HaystackAnalytics.

FACE TO FACE: Dr Kanury V S Rao, Co-Founder & CSO,...

In a highly informative conversation, Dr Kanury V S Rao, Co-Founder & Chief Scientific Officer, PredOmix spoke to Rahul Koul, Chief Editor, BioVoice News...

Dr Ramesh Venkata Sonti is the new Director of ICGEB

He succeeds Dr Dinakar M. Salunke who was at the helm for over six years

BioVoice eMagazine December 2022 Issue 3 Volume 3

Click to Read: BioVoice eMagazine December 2022 Issue 3 Volume 3 The Cover Story in the current edition focuses on India's strong biotech R&D segment...

Exclusive: Antibody against multiple emerging SARS-CoV-2 variants

A broadly neutralizing highly potent human monoclonal antibody developed in India against multiple emerging SARS-CoV-2 variants

IIT Mandi researchers discover Phytochemicals that inhibit the COVID-19 virus

Researchers from the Indian Institute of Technology Mandi and The International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, have identified Phytochemicals in the petals of a Himalayan plant that could potentially be used to treat COVID-19 infections

COVID-19: ICGEB-Emory Vaccine Center’s fresh study offers hope to improve plasma therapy...

A new study by the ICGEB-Emory Vaccine Center offers hope to improve plasma therapy regimen in India..................

Sun Pharma initiates Phase II clinical trial of first phytopharma drug...

Clinical trial of the drug that has shown anti-SARS-CoV-2 effects in in-vitro studies conducted in collaboration with ICGEB will be conducted across 12 centers in India in 210 patients; results expected by October 2020.............................

ICGEB scientists alter fungal genome to double enzyme production for biofuel...

This finding is particularly significant in India considering the government is planning to set-up twelve (12) 2G-ethanol biorefineries across India using cellulosic feedstock...........